1 |
Akoumianakis, I. and Sanna, F. 2019. Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of nadph oxidases. Sci. Transl. Med. 11, 510.
|
2 |
An, S., Zhao L. P., Shen, L. J., Wang, S., Zhang, K., Qi Y., Zheng, J. ,Zhang, X. J., Zhu, X. Y., Bao, R., Yang, L., Lu, Y. X., She, Z. G. and Tang, Y. D. 2017. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. Hepatology 66, 1866-1884.
DOI
|
3 |
Darling, S., Fielding, A. B., Sabat-Pospiech, D., Prior, I. A. and Coulson, J. M. 2017. Regulation of the cell cycle and centrosome biology by deubiquitylases. Biochem. Soc. Trans. 45, 1125-1136.
DOI
|
4 |
Gao, Y., Koppen, A., Rakhshandehroo, M., Tasdelen, I., van de Graaf, S. F., van Loosdregt, J., van Beekum, O., Hamers, N., van Leenen, D., Berkers, C. R., Berger, R., Holstege, F. C., Coffer, P. J., Brenkman, A. B., Ovaa, H. and Kalkhoven, E. 2013. Early adipogenesis is regulated through USP7-mediated deubiquitination of the histone acetyltransferase TIP60. Nat. Commun. 4, 2656.
DOI
|
5 |
Jacq, X., Kemp, M., Martin, N. M. and Jackson, S. P. 2013. Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem. Biophys. 67, 25-43.
DOI
|
6 |
Kwasna, D., Abdul Rehman, S. A., Natarajan, J., Matthews, S., Madden, R., De Cesare, V., Weidlich, S., Virdee, S., Ahel, I., Gibbs-Seymour, I. and Kulathu, Y. 2018. Discovery and characterization of ZUFSP/ZUP1, a distinct deubiquitinase class important for genome stability. Mol. Cell 70, 150-164.e156.
DOI
|
7 |
Li, S., Zhang, H. and Wei, X. 2021. Roles and mechanisms of deubiquitinases (DUBs) in breast cancer progression and targeted drug discovery. Life (Basel) 11, 9.
|
8 |
Liu, B., Jiang, S., Li, M., Xiong, X., Zhu, M., Li, D., Zhao, L., Qian, L., Zhai, L. and Li, J. 2018. Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN. Nat. Commun. 9, 4770.
DOI
|
9 |
Sadler, J. B. A., Lamb, C. A., Welburn, C. R., Adamson, I. S., Kioumourtzoglou, D., Chi, N. W., Gould, G. W. and Bryant, N. J. 2019. The deubiquitinating enzyme USP25 binds tankyrase and regulates trafficking of the facilitative glucose transporter GLUT4 in adipocytes. Sci. Rep. 9, 4710.
DOI
|
10 |
Seki, E. 2014. TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis. Mol. Cell Oncol. 1, e968507.
DOI
|
11 |
Suzuki, M., Setsuie, R. and Wada, K. 2009. Ubiquitin carboxyl-terminal hydrolase l3 promotes insulin signaling and adipogenesis. Endocrinology 150, 5230-5239.
DOI
|
12 |
Tang, Y., Lv, L., Li, W., Zhang, X., Jiang, Y., Ge, W. and Zhou, Y. 2017. Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells. Stem. Cell. Res. Ther. 8, 186.
DOI
|
13 |
Yan, F. J., Zhang, X. J., Wang, W. X., Ji, Y. X., Wang, P. X., Yang, Y., Gong, J., Shen, L. J., Zhu, X. Y., Huang, Z. and Li, H. 2017. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology 65, 1492-1511.
DOI
|
14 |
Coyne, E. S., Bedard, N., Gong, Y. J., Faraj, M., Tchernof, A. and Wing, S. S. 2019. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. Diabetologia 62, 136-146.
DOI
|
15 |
Ghemrawi, R., Battaglia-Hsu, S. F. and Arnold, C. 2018. Endoplasmic reticulum stress in metabolic disorders. Cells 7, 63.
DOI
|
16 |
Lim, K. H., Choi, J. H., Park, J. H., Cho, H. J., Park, J. J., Lee, E. J., Li L., Choi, Y. K. and Baek, K. H. 2016. Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A. Oncotarget 7, 34759-34772.
DOI
|
17 |
Zhu, S., Hou, S., Lu, Y., Sheng, W., Cui, Z., Dong, T., Feng, H. and Wan, Q. 2021. USP36-mediated deubiquitination of DOCK4 contributes to the diabetic renal tubular epithelial cell injury via WNT/β-catenin signaling pathway. Front. Cell. Dev. Biol. 9, 638477.
DOI
|
18 |
Mennerich, D., Kubaichuk, K. and Kietzmann, T. 2019. DUBs, hypoxia, and cancer. Trends Cancer 5, 632-653.
DOI
|
19 |
Mukherjee, A., Morales-Scheihing, D., Butler, P. C. and Soto, C. 2015. Type 2 diabetes as a protein misfolding disease. Trends. Mol. Med. 21, 439-449.
DOI
|
20 |
Ji, Y. X. and Huang, Z. 2018. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat. Med. 24, 213-223.
DOI
|
21 |
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F. and Miele, C. 2019. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int. J. Mol. Sci. 20, 9.
DOI
|
22 |
Mevissen, T. E. T. and Komander, D. 2017. Mechanisms of deubiquitinase specificity and regulation. Annu. Rev. Biochem. 86, 159-192.
DOI
|
23 |
Poondla, N., Chandrasekaran, A. P., Kim, K. S. and Ramakrishna, S. 2019. Deubiquitinating enzymes as cancer biomarkers: New therapeutic opportunities? BMB Rep. 52, 181-189.
DOI
|
24 |
Sharma, A., Alswillah, T., Singh, K., Chatterjee, P., Willard, B., Venere, M., Summers, M. K. and Almasan, A. 2018. USP14 regulates DNA damage repair by targeting RNF 168-dependent ubiquitination. Autophage 14, 1976-1990.
DOI
|
25 |
Urbe, S., Liu, H., Hayes, S. D., Heride, C., Rigden, D. J. and Clague, M. J. 2012. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosomeand microtubule-associated functions. Mol. Biol. Cell 23, 1095-1103.
DOI
|
26 |
Liu, B., Zhang, Z., Hu, Y., Lu, Y., Li, D., Liu, J., Liao, S., Hu, M., Wang, Y., Zhang, D., Chen, Y., Qian, Q., Lv, X., Wu, D., Tan, M., Hu, C., Xiong, X. and Li, X. 2019. Sustained er stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP 14. Proc. Natl. Acad. Sci. USA. 116, 21732-21738.
DOI
|
27 |
Gonidas, C., Hadweh, P. and Mosialos, G. 2022. Deubiquitinating enzymes at the crossroads of lipid metabolism and cancer. J. Biol. Res.-Thessalon. 29, 1.
|